Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

Pathway for Softgel vs Tablet Comparison [Design Issues]

posted by jag009 – NJ, 2018-05-18 18:33 (2553 d 19:37 ago) – Posting: # 18786
Views: 3,154

Hi,

❝ However I have a case where a BE study was conducted comparing Metronidazole tablet (Reference) with Metronidazole soft gel (test). Both were IR. Is this acceptable?

Have you read this guidance? FDA

John

Complete thread:

Bioequivalence of IR vs MR tablet heritage 2018-05-05 06:25
- Consider 505(b)(2) Pathway bebac_fan 2018-05-05 17:08
  - Pathway for Softgel vs Tablet Comparison Obinoscopy 2018-05-15 19:04
    - Pathway for Softgel vs Tablet Comparisonjag009 2018-05-18 16:33

Admin contact
23,424 posts in 4,927 threads, 1,669 registered users;
92 visitors (0 registered, 92 guests [including 57 identified bots]).
Forum time: 14:10 CEST (Europe/Vienna)

Don’t undertake a project
unless it’s manifestly important
and nearly impossible. Edwin H. Land

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz